支架联合双联抗血小板治疗对动脉瘤性蛛网膜下腔出血后脑血管痉挛和迟发性脑缺血的影响
本研究基于前瞻性机构数据库,比较支架辅助栓塞/血流导向联合双联抗血小板治疗(S-DAPT)与无需抗血小板的血管内治疗患者,经倾向评分匹配后分析。
要点
- S-DAPT与中重度血管造影性血管痉挛风险显著降低相关。
- DCI风险在S-DAPT组数值更低但差异无统计学意义。
- 获益在Hunt-Hess 1-3级患者中显著。
核心结论
- S-DAPT与动脉瘤性蛛网膜下腔出血后脑血管痉挛风险降低相关。
- 需更大样本研究评估对DCI的影响。
研究设计与样本
- 前瞻性机构数据库查询,比较S-DAPT组与匹配的无抗血小板对照组。
- 倾向评分匹配年龄、性别、Hunt-Hess分级和改良Fisher评分。
- 共285例血管内治疗的aSAH患者,29%接受S-DAPT。
主要发现
- 总体DCI发生率为24.2%。
临床怎么用
- 对于接受支架辅助栓塞或血流导向装置并需DAPT的aSAH患者,可关注血管痉挛风险的降低。
- DCI预防的获益尚不明确,需个体化评估。
局限性
- DCI差异未达统计学显著性,研究效能不足。
- 为单中心前瞻性数据库的回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: As stent-assisted coiling and flow diversion permeate the treatment armamentarium for appropriately selected ruptured aneurysms, the effect of dual antiplatelet therapy (DAPT) on hemorrhagic complications is primarily scrutinized. However, the effect of DAPT and the presence of a stent on vasospasm and delayed cerebral ischemia (DCI) is less well studied. METHODS: Our prospectively maintained institutional database of intracranial aneurysms was queried for DCI and postaneurysmal subarachnoid hemorrhage (aSAH) vasospasm among patients undergoing stent coiling/flow diversion with subsequent usage of DAPT (S-DAPT). This group was compared with a matched control cohort of patients treated endovascularly not requiring antiplatelets (No S-DAPT). A propensity score was matched for age, sex, presenting clinical (Hunt-Hess), and radiographic (modified Fisher score) grade. Subgroup analyses were stratified by Hunt-Hess grade and DAPT regimen. Impact sizes were adjusted in multivariate analyses. RESULTS: Of 285 aSAH patients treated endovascularly over the evaluated period, 29% underwent S-DAPT. DCI occurred in 24.2% overall. The S-DAPT group showed a significant reduction in moderate or severe angiographic vasospasm (37% vs 55%, P = .02). The DCI risk was lower numerically (18% vs 27%), although this difference was not statistically significant ( P = .14). Subgroup analyses of angiographic vasospasm identified the benefit of S-DAPT in grade 1-3 aSAH (95% CI of absolute-risk-reduction [7.9%-35.8%], P = .003). The synergistic effect of S-DAPT was associated with a 2-fold lower risk of angiographic vasospasm in multivariate analyses (adjusted odds ratio 0.47, 95% CI [0.26-0.85], P = .01). CONCLUSION: S-DAPT was associated with a lower risk of post-aSAH cerebral vasospasm. Future studies with greater power to evaluate the effect on DCI as well are warranted.
引用
- Ma L, Jacobs RC, Agarwal P, et al. Delayed Cerebral Ischemia and Vasospasm After Aneurysmal Subarachnoid Hemorrhage: Impact of Stents and Dual Antiplatelet Therapy. Neurosurgery. 2025. PMID: 40903458. doi:10.1227/neu.0000000000003621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。